Sign In
Buy TWST
$72.33
+2.18 (+3.11%)
At Close: Jun 03, 2026
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
01:10pm, Tuesday, 02'nd Jun 2026
Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine spotlighting stocks like PACB, MYGN and TWST.
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
08:00am, Wednesday, 27'th May 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder
Twist Bioscience Corporation (TWST) Analyst/Investor Day Transcript
11:07am, Tuesday, 26'th May 2026
Twist Bioscience Corporation (TWST) Analyst/Investor Day Transcript
LenioBio and Twist Bioscience Enter into a Collaboration to Further Enable AI drug-discovery
09:08am, Friday, 08'th May 2026
DÜSSELDORF, Germany--(BUSINESS WIRE)--LenioBio GmbH, a TechBio company commercializing its ALiCE® cell-free protein expression platform, today announced a collaborative agreement with Twist Bioscien
Twist Bioscience: AI Momentum Is Real, But The Easy Money Has Been Made
09:45am, Thursday, 07'th May 2026
Twist Bioscience (TWST) delivered strong Q2 results, driven by AI-enabled drug discovery. NGS growth was soft due to a demand air pocket caused by a large customer. Growth is expected to rebound as th
These Analysts Boost Their Forecasts On Twist Bioscience After Q2 Results
02:36pm, Tuesday, 05'th May 2026
Twist Bioscience Corporation (NASDAQ:TWST) on Monday reported a loss for its fiscal 2026 second quarter.
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08:00am, Tuesday, 05'th May 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and
Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call Transcript
01:53pm, Monday, 04'th May 2026
Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call Transcript
AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens
01:46pm, Monday, 04'th May 2026
Twist Bioscience Corporation (NASDAQ:TWST) shares are down on Monday as the company reported its fiscal 2026 second-quarter financial results.
Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates
09:25am, Monday, 04'th May 2026
Twist Bioscience (TWST) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.66 per share a year ago.
Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences
07:20am, Monday, 04'th May 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today expanded its clonal genes portfolio with the early access l
Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results
07:15am, Monday, 04'th May 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the
Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026
08:00am, Tuesday, 21'st Apr 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for the
Adam Laponis Sells 2,597 Shares of Twist Bioscience (NASDAQ:TWST) Stock
04:27am, Wednesday, 15'th Apr 2026
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) CFO Adam Laponis sold 2,597 shares of the company's stock in a transaction that occurred on Thursday, April 9th. The shares were sold at a
Twist Bioscience (NASDAQ:TWST) Director Sells $51,000.00 in Stock
04:48am, Monday, 06'th Apr 2026
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) Director Melissa Starovasnik sold 1,000 shares of the firm's stock in a transaction dated Wednesday, April 1st. The stock was sold at an a
